| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new use for an old drug provides dual glucose and LDL-lowering therapy in the modern setting of T2D Management: Colesevelam HCL
|
Goldberg, Ronald B.
|
|
2009
|
9 |
5 |
p. 331-332
|
artikel
|
| 2 |
Fiber facts: Benefits and recommendations for individuals with type 2 diabetes
|
Vuksan, Vladimir
|
|
2009
|
9 |
5 |
p. 405-411
|
artikel
|
| 3 |
Is the evidence from clinical trials for cardiovascular risk or harm for glitazones convincing?
|
Mannucci, Edoardo
|
|
2009
|
9 |
5 |
p. 342-347
|
artikel
|
| 4 |
Low-carbohydrate diets: An update on current research
|
Wylie-Rosett, Judith
|
|
2009
|
9 |
5 |
p. 396-404
|
artikel
|
| 5 |
New therapies for diabesity
|
Bailey, Clifford J.
|
|
2009
|
9 |
5 |
p. 360-367
|
artikel
|
| 6 |
The usefulness of a Mediterranean-based diet in individuals with type 2 diabetes
|
Champagne, Catherine M.
|
|
2009
|
9 |
5 |
p. 389-395
|
artikel
|
| 7 |
Treating diabetes and prediabetes by focusing on obesity management
|
Khaodhiar, Lalita
|
|
2009
|
9 |
5 |
p. 348-354
|
artikel
|
| 8 |
Use of the glycemic index for weight loss and glycemic control: A review of recent evidence
|
Vega-López, Sonia
|
|
2009
|
9 |
5 |
p. 379-388
|
artikel
|
| 9 |
Using meal replacements as a nutritional strategy for weight loss in type 2 diabetes
|
Otto, Amy D.
|
|
2009
|
9 |
5 |
p. 329-330
|
artikel
|
| 10 |
What are the best options for controlling prandial glycemia?
|
Clement, Stephen
|
|
2009
|
9 |
5 |
p. 355-359
|
artikel
|
| 11 |
What are the risks and the benefits of current and emerging weight-loss medications?
|
Robinson, Jamie R.
|
|
2009
|
9 |
5 |
p. 368-375
|
artikel
|
| 12 |
What is the best treatment for prediabetes?
|
Sharma, Morali D.
|
|
2009
|
9 |
5 |
p. 335-341
|
artikel
|
| 13 |
When is evidence of lack of harm enough? Has the rosiglitazone controversy ended?
|
McCall, Anthony L.
|
|
2009
|
9 |
5 |
p. 325-328
|
artikel
|
Tijdschrift beschrijving